Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,344 public trials 2,835 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Recruiting

A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant

NCT07006506

Conditions: Graft Versus Host Disease, Graft vs Host Disease, Hematologic Diseases, +6 more
Locations: Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States

Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity) Commack, New York, United States

View Trial Details

Recruiting

Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia

NCT03571321

Conditions: ALL, ALL, Childhood, Acute Lymphoblastic Leukemia, +11 more
Locations: University of Chicago Medical Center Chicago, Illinois, United States

The University of Texas Southwestern Medical Center Dallas, Texas, United States

View Trial Details

Recruiting

A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma

NCT07323654

Conditions: Eosinophilia, Eosinophilic Asthma, Hematologic Diseases, +6 more
Locations: Kymera Investigative Site Lancaster, California, United States

Kymera Investigative Site Long Beach, California, United States

Kymera Investigative Site Northridge, California, United States

Kymera Investigative Site Redding, California, United States

View all 58 locations

View Trial Details

Recruiting

Iberdomide and Daratumumab as Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma

NCT06107738

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Karmanos Cancer Institute Detroit, Michigan, United States

KCI at McLaren Greater Lansing Lansing, Michigan, United States

View Trial Details

Recruiting

A Non-interventional Study of Melphalan Flufenamide (Melflufen) (Pepaxti®) and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma (R/RMM)

NCT07559799

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Praxis für interdisziplinäre Onkologie & Hämatologie Freiburg im Breisgau, Germany

View Trial Details

Recruiting

Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)

NCT06802315

Conditions: Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, Relapsed, Adult, Bone Marrow Diseases, +17 more
Locations: University of Illinois Cancer Center Chicago, Illinois, United States

View Trial Details

Recruiting

A Study of MRD-Guided Zanubrutinib Plus Sonrotoclax in Treatment-Naïve, High-Risk CLL/SLL Patients

NCT07671378

Conditions: CLL (Chronic Lymphocytic Leukemia), Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Jiangsu Province Hospital Nanjing, Jiangsu, China

View Trial Details

Recruiting

A Study of Iptacopan in Korean Patients With Paroxysmal Nocturnal Hemoglobinuria or C3 Glomerulopathy

NCT07416162

Conditions: Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +23 more
Locations: Novartis Investigative Site Jeollanam, South Korea

Novartis Investigative Site Seoul, South Korea

Novartis Investigative Site Seoul, South Korea

View Trial Details

Recruiting

Olutasidenib in Relapsed IDH1 Mutated AML Patients Who Have Previously Received Venetoclax

NCT07471841

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, IDH1 Mutation, +6 more
Locations: Atrium Health Wake Forest Baptist Medical Center Winston-Salem, North Carolina, United States

View Trial Details

Recruiting

DR-18 to Prevent or Treat Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse After Hematopoietic Cell Transplantation, the DR. DREAM Trial

NCT06492707

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +10 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Hematologic Diseases

Hematologic Diseases trial results

Related conditions